Literature DB >> 23945664

Differentiating haemostasis from thrombosis for therapeutic benefit.

J D McFadyen1, S P Jackson.   

Abstract

The central role of platelets in the formation of the primary haemostatic plug as well as in the development of arterial thrombosis is well defined. In general, the molecular events underpinning these processes are broadly similar. Whilst it has long been known that disturbances in blood flow, changes in platelet reactivity and enhanced coagulation reactions facilitate pathological thrombus formation, the precise details underlying these events remain incompletely understood. Intravital microscopy studies have highlighted the dynamic and heterogeneous nature of thrombus development and demonstrated that there are considerable spatiotemporal differences in the activation states of platelets within a forming thrombus. In this review we will consider the factors regulating the activation state of platelets in a developing thrombus and discuss how specific prothrombotic factors may influence this process, leading to excessive thrombus propagation. We will also discuss some potentially novel therapeutic approaches that may reduce excess thrombus development whilst minimising bleeding risk.

Entities:  

Keywords:  Thrombosis; antiplatelet agents; atherothrombosis

Mesh:

Substances:

Year:  2013        PMID: 23945664     DOI: 10.1160/TH13-05-0379

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Polyphosphate, platelets, and coagulation.

Authors:  R J Travers; S A Smith; J H Morrissey
Journal:  Int J Lab Hematol       Date:  2015-05       Impact factor: 2.877

Review 2.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 3.  Current and future antiplatelet therapies: emphasis on preserving haemostasis.

Authors:  James D McFadyen; Mathieu Schaff; Karlheinz Peter
Journal:  Nat Rev Cardiol       Date:  2018-01-03       Impact factor: 32.419

4.  Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.

Authors:  Moua Yang; Brian C Cooley; Wei Li; Yiliang Chen; Jeannette Vasquez-Vivar; Na'il O Scoggins; Scott J Cameron; Craig N Morrell; Roy L Silverstein
Journal:  Blood       Date:  2017-03-23       Impact factor: 22.113

5.  FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.

Authors:  Shu Zhu; Richard J Travers; James H Morrissey; Scott L Diamond
Journal:  Blood       Date:  2015-07-01       Impact factor: 22.113

6.  Transport regulation of two-dimensional receptor-ligand association.

Authors:  Lining Ju; Jin Qian; Cheng Zhu
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

7.  Thrombosis: Novel nanomedical concepts of diagnosis and treatment.

Authors:  Iwona Cicha
Journal:  World J Cardiol       Date:  2015-08-26

8.  Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.

Authors:  Richard J Travers; Rajesh A Shenoi; Manu Thomas Kalathottukaren; Jayachandran N Kizhakkedathu; James H Morrissey
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

9.  Continuous Modeling of Arterial Platelet Thrombus Formation Using a Spatial Adsorption Equation.

Authors:  Evgenia S Babushkina; Nikolay M Bessonov; Fazoil I Ataullakhanov; Mikhail A Panteleev
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 10.  Targeting GPVI as a novel antithrombotic strategy.

Authors:  Robert K Andrews; Jane F Arthur; Elizabeth E Gardiner
Journal:  J Blood Med       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.